Denali Therapeutics (DNLI) CEO Ryan Watts donates 32,220 shares to charitable fund
Rhea-AI Filing Summary
Denali Therapeutics Inc. President and CEO Ryan J. Watts reported a bona fide gift of 32,220 shares of Denali common stock on August 12, 2026. The in-kind charitable contribution was made to a donor advised fund from shares held indirectly through the Watts Family 2015 Trust, for which he serves as trustee. After the transactions, he reports 2,120,384 indirect shares and 296,833 direct shares, including 184,915 unvested RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 32,220 shares
Net Sell
2 txns
Insider
Watts Ryan J.
Role
President and CEO
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Gift | Common Stock F1, F2 | 32,220 | $0.00 | $0.00 |
| holding | Common Stock F3 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 2,120,384 shares (Indirect, See footnote);
Common Stock — 296,833 shares (Direct)
Footnotes (3)
- F1. Reflects an in-kind charitable contribution of 32,220 shares of DNLI to a donor advised fund.
- F2. The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
- F3. Includes 184,915 unvested RSUs.
Key Figures
Shares gifted: 32,220 shares
Indirect holdings after transaction: 2,120,384 shares
Direct holdings after transaction: 296,833 shares
+2 more
5 metrics
Shares gifted
32,220 shares
In-kind charitable contribution to a donor advised fund on August 12, 2026
Indirect holdings after transaction
2,120,384 shares
Common stock held indirectly after the gift, via Watts Family 2015 Trust
Direct holdings after transaction
296,833 shares
Common stock held directly by Ryan J. Watts following the reported transactions
Unvested RSUs included in direct holdings
184,915 RSUs
Portion of direct position represented by unvested restricted stock units
Gift price per share
$0.0000 per share
Reported transaction price for the bona fide gift of common stock
Key Terms
bona fide gift, donor advised fund, unvested RSUs, indirect ownership
4 terms
bona fide gift financial
"The transaction code G is described as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
donor advised fund financial
"An in-kind charitable contribution of 32,220 shares of DNLI to a donor advised fund."
A donor advised fund is a charitable savings account you fund with cash or assets (including stocks) that lets you take an immediate tax benefit while recommending when and which charities receive grants over time. Think of it like a dedicated piggy bank for giving: you get tax relief when you put money in, can avoid selling appreciated securities and triggering capital gains, and still control the timing and recipients of donations, which affects tax planning, portfolio decisions, and public giving signals.
unvested RSUs financial
"Includes 184,915 unvested RSUs."
indirect ownership financial
"The shares are held of record by the Watts Family 2015 Trust, indicating indirect ownership."
FAQ
What did Denali Therapeutics (DNLI) CEO Ryan Watts report in this Form 4?
Ryan J. Watts reported a bona fide gift of 32,220 DNLI shares on August 12, 2026. The in-kind contribution went from a trust he oversees to a donor advised fund, with no sale proceeds reported.
What are Ryan Watts’ remaining DNLI holdings after this Form 4 transaction?
After the reported transactions, Ryan Watts reports 2,120,384 indirectly held DNLI shares and 296,833 directly held shares. The direct holdings figure includes 184,915 unvested RSUs, as disclosed in the footnotes.
Are unvested RSUs included in Ryan Watts’ reported DNLI holdings?
Yes. The filing states his 296,833 directly held DNLI shares include 184,915 unvested RSUs. This means a substantial portion of his direct position consists of restricted stock units that have not yet vested.
AI-generated analysis. How Rhea-AI works. Not financial advice.
